The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The MD Anderson modified cyclophosphamide, bortezomib, doxorubicin, and dexamethasone (mCBAD) for the treatment of newly diagnosed (NDMM) and relapsed/refractory multiple myeloma (RRMM).
 
Samer Tabchi
No Relationships to Disclose
 
Ranjit Nair
No Relationships to Disclose
 
Krina K. Patel
Honoraria - Targeted Oncology
Consulting or Advisory Role - Amgen; Celgene; Hikma Pharmaceuticals; Juno Therapeutics
Research Funding - Celgene (Inst); Janssen (Inst); poseida therapeutics (Inst); Takeda (Inst)
 
Hans Chulhee Lee
Consulting or Advisory Role - Adaptive Biotechnologies; Celgene; Pimera; Takeda
Research Funding - Amgen; Daiichi Sankyo; Janssen; Takeda
 
Sheeba K. Thomas
Consulting or Advisory Role - Amgen
Research Funding - Acerta Pharma (Inst); Amgen (Inst); Array BioPharma; Bristol-Myers Squibb; Celgene; Idera
 
Behrang Amini
No Relationships to Disclose
 
Sairah Ahmed
No Relationships to Disclose
 
Rohtesh S. Mehta
No Relationships to Disclose
 
Qaiser Bashir
Stock and Other Ownership Interests - Kite, a Gilead company
Consulting or Advisory Role - Spectrum Pharmaceuticals; Takeda
Research Funding - Celgene; Takeda (Inst)
 
Muzaffar H. Qazilbash
No Relationships to Disclose
 
Donna M. Weber
No Relationships to Disclose
 
Robert Z. Orlowski
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Kite, a Gilead company; Sanofi; Takeda
Research Funding - Amgen; BioTheryX; Spectrum Pharmaceuticals
 
Raymond Alexanian
No Relationships to Disclose
 
Lei Feng
No Relationships to Disclose
 
Elisabet Esteve Manasanch
Honoraria - Adaptive Biotechnologies; Takeda
Consulting or Advisory Role - Celgene
Research Funding - Merck; Quest Diagnostics; Sanofi